India Stem Cell Market Size, Share, Trends & Forecast 2033

India Stem Cell Market Size, Share, Trends and Forecast by Product, Application, Technology, Therapy, End User, and Region, 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A29874

Buy Now Discount
Offer

India Stem Cell Market Overview:

The India stem cell market size reached USD 0.49 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1.32 Million by 2033, exhibiting a growth rate (CAGR) of 11.50% during 2025-2033. The market is broadening with improving regenerative medicine, increasing biotech research investment, higher occurrences of chronic disease, and wider awareness of stem cell banking. Government support to biotechnology, need for targeted medicine, and partnerships between private companies and research institutions are further driving the growth of the market.

Report Attribute	Key Statistics
Base Year	2024
Forecast Years	2025-2033
Historical Years	2019-2024
Market Size in 2024	USD 0.49 Million
Market Forecast in 2033	USD 1.32 Million
Market Growth Rate (2025-2033)	11.50%

India Stem Cell Market Trends:

Expansion of Stem Cell Banking and Cord Blood Storage

Stem cell banking is witnessing immense traction in India as people become increasingly aware of its therapeutic possibilities in treating genetic diseases, blood disorders, and regenerative use. There is a demand surge for the storage of cord blood stem cells in response to parental interest in establishing enduring health safeguards for their children. Prominent market players are investing in advanced cryopreservation technology centers and expanding services. Government incentives in the form of regulations encouraging ethical stem cell banking and public-private partnerships are also fueling accessibility. Moreover, innovations in automated processing and storage technologies are improving the viability and potency of stored stem cells, making India a central hub for stem cell preservation in the Asia-Pacific region. For instance, in November 2023, CryoVault India received the "Best Stem Cell Bank in India" award from Telangana's Health Minister at the hmtv Healthcare Awards 2023.

Increasing Applications in Regenerative Medicine and Cell Therapy

Regenerative medicine is revolutionizing healthcare, with stem cells playing a critical role in the treatment of neurodegenerative disorders, cardiovascular diseases, orthopedic injuries, and diabetes. India is witnessing a surge in clinical trials and research focused on mesenchymal stem cells (MSCs) and induced pluripotent stem cells (iPSCs) for regenerative therapies. Hospitals and research institutes are partnering with biotechnology firms to accelerate commercialization. For instance, in February 2024, India conducted its first human clinical trial of gene therapy for haemophilia A at CMC Vellore, supported by the Department of Biotechnology and Emory University. The adoption of autologous stem cell therapies, where a patient’s own cells are used for treatment, is gaining traction due to minimal risk of rejection. With advancements in gene editing technologies such as CRISPR and improved differentiation protocols, the market is expected to see a broader range of therapeutic applications, attracting investment from domestic and international players.

Government and Private Sector Investments in Stem Cell Research

The Indian government is actively promoting stem cell research through funding programs, collaborations, and regulatory support. Initiatives like the Department of Biotechnology’s (DBT) National Biopharma Mission and investments from private biotech firms are accelerating research in stem cell-based therapies. India’s affordable clinical trial ecosystem, combined with a strong network of research institutions, is fostering innovation in cell-based treatments. Startups and multinational pharmaceutical companies are entering the market, leveraging India’s cost-effective research and skilled workforce. The development of GMP-certified (Good Manufacturing Practice) stem cell processing facilities is also increasing, ensuring compliance with global quality standards. These investments are expected to make India a leader in stem cell innovations, driving accessibility and affordability of therapies in the long run. For instance, in December 2024, Phase 2 clinical trials for CD19-directed CAR T-cell therapy were approved for children and adults with B-ALL and B-NHL. This therapy, developed by IIT Bombay and Tata Memorial Center, received Drug Controller General of India (DCGI) approval in March 2021 for Phase 1 trials, which have now been completed. The therapy has demonstrated safety and effectiveness, aligning with global standards. Research and development efforts continue with government support for expanding CAR T-cell applications in India.

India Stem Cell Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region/country level for 2025-2033. Our report has categorized the market based on product, application, technology, therapy, and end user.

Product Insights:

Adult Stem Cells (ASCs)
Human Embryonic Stem Cells (HESCs)
Induced Pluripotent Stem Cells (iPSCs)
Very Small Embryonic Like Stem Cells

The report has provided a detailed breakup and analysis of the market based on the product. This includes adult stem cells (ASCs), human embryonic stem cells (HESCs), induced pluripotent stem cells (iPSCs), and very small embryonic like stem cells.

Application Insights:

Regenerative Medicine
Drug Discovery and Development

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes regenerative medicine and drug discovery and development.

Technology Insights:

Cell Acquisition
Cell Production
Cryopreservation
Expansion and Sub-Culture.

A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes cell acquisition, cell production, cryopreservation, and expansion and sub-culture.

Therapy Insights:

Autologous
Allogeneic

A detailed breakup and analysis of the market based on the therapy have also been provided in the report. This includes autologous and allogeneic.

End User Insights:

Pharmaceuticals and Biotechnology Companies
Hospitals and Cell Banks
Academic and Research Institutes

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes pharmaceuticals and biotechnology companies, hospitals and cell banks, and academic and research institutes.

Regional Insights:

North India
South India
East India
West India

The report has also provided a comprehensive analysis of all the major regional markets, which include North, South, East, and West India.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

India Stem Cell Market News:

In July 2024, Bioserve India, a subsidiary of REPROCELL, launched advanced stem cell products in India, enhancing research in regenerative medicine and drug discovery. The product line includes cell culture solutions, reprogramming kits, 3D cell culture systems, and cellular assays. With a global biorepository of 600,000 biospecimens, the launch aims to accelerate stem cell research in India.
In February 2024, Miltenyi Biotec launched its first India office in Hyderabad, investing in a Cell and Gene Therapy Center of Excellence (COE). The company will provide training and access to CGT technologies for Indian researchers and clinicians, from proof-of-concept to commercialization. Miltenyi aims to drive affordable CGT therapies in India, leveraging its CliniMACS Prodigy platform. The initiative highlights Miltenyi's commitment to fostering knowledge exchange and local manufacturing, with a focus on CAR T-cell therapy development.

India Stem Cell Market Report Coverage:

Report Features	Details
Base Year of the Analysis	2024
Historical Period	2019-2024
Forecast Period	2025-2033
Units	Million USD
Scope of the Report	Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment: Product Application Technology Therapy End User Region
Products Covered	Adult Stem Cells (ASCs), Human Embryonic Stem Cells (HESCs), Induced Pluripotent Stem Cells (iPSCs), Very Small Embryonic Like Stem Cells
Applications Covered	Regenerative Medicine, Drug Discovery And Development
Technologies Covered	Cell Acquisition, Cell Production, Cryopreservation, Expansion and Sub-Culture
Therapies Covered	Autologous, Allogeneic
End Users Covered	Pharmaceuticals and Biotechnology Companies, Hospitals and Cell Banks, Academic and Research Institutes
Regions Covered	North India, South India, East India, West India
Customization Scope	10% Free Customization
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

How has the India stem cell market performed so far and how will it perform in the coming years?
What is the breakup of the India stem cell market on the basis of product?
What is the breakup of the India stem cell market on the basis of application?
What is the breakup of the India Stem cell market on the basis of technology?
What is the breakup of the India stem cell market on the basis of therapy?
What is the breakup of the India stem cell market on the basis of end user?
What are the various stages in the value chain of the India stem cell market?
What are the key driving factors and challenges in the India stem cell?
What is the structure of the India stem cell market and who are the key players?
What is the degree of competition in the India stem cell market?

Key Benefits for Stakeholders:

IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the India stem cell market from 2019-2033.
The research report provides the latest information on the market drivers, challenges, and opportunities in the India stem cell market.
Porter's Five Forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the India stem cell industry and its attractiveness.
Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Purchase Options Discount
Offer

Inquire Before Buying

Speak to an Analyst

Request Brochure

Request Customization

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.